Biliary Stents Industry
The global biliary stents market size is estimated to reach USD 197.96 million by 2030, based on a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.0% from 2024 to 2030. The market is experiencing robust growth, driven by the escalating incidence of biliary disorders and chronic liver diseases. In the U.S., liver cancer annually affects around 25,000 men and 11,000 women, resulting in a substantial mortality rate, according to the CDC report. This upward trajectory is further propelled by advancements in stent types, a growing geriatric population, heightened healthcare awareness, and a rising preference for minimally invasive procedures.
According to the NCBI article published in April 2023, a pivotal factor contributing to market expansion is the widespread adoption of endoscopic luminal stenting (ELS). ELS has emerged as a minimally invasive and highly effective solution for managing malignant obstructions in the gastrointestinal tract, particularly biliary obstructions. Its superiority over traditional modalities like radiotherapy and surgery positions it as a preferred first-line application in palliative and neoadjuvant settings.
The dynamic evolution of stent types, addressing the demand for heightened efficacy, safety, and adaptability to cutting-edge technologies, serves as a catalyst for the continued growth and relevance of the market. Despite these positive trends, the impact of reduced cancer screening initiatives during the COVID-19 pandemic has introduced challenges, leading to a notable decline in newly diagnosed cancer cases.
Gather more insights about the market drivers, restrains and growth of the Global Biliary Stents market
Biliary Stents Market Segments Highlights:
- In 2023, North America held the market's largest revenue share of 43.69%. The region's advanced healthcare infrastructure, increasing awareness about gastrointestinal health, and a growing aging population contribute to the market's dominance
- Based on type, the metal segment dominated the biliary stents industry with a revenue share of 66.99% in 2023. The growth of metal is propelled by the advent of fully covered self-expandable metal stents (FCSEMS)
- Based on application, the gallstones segment dominated the market with a revenue share of 41.28% in 2023. A significant driving force in this expansion is the increasing prevalence of gallstone-related conditions, prompting a growing demand for effective and minimally invasive interventions
- In terms of end-use, the hospitals segment dominated the market with a revenue share of 74.23%. Hospitals primarily contribute to the market growth serving as prime centers for comprehensive medical care
Biliary Stents Market Report Segmentation
Grand View Research has segmented the global biliary stents market based on type, application, end-use, and region-
Biliary Stents Type Outlook (Revenue, USD Million, 2018 - 2030)
Biliary Stents Application Outlook (Revenue, USD Million, 2018 - 2030)
- Bilio-pancreatic Leakages
- Pancreatic Cancer
- Benign Biliary Structures
- Gallstones
- Others
Biliary Stents End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
Biliary Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Norway
- Denmark
- Asia Pacific
- China
- Japan
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Kuwait
Key Biliary Stents Company Insights
- Cook Group
- Boston Scientific
- ENDO-FLEX GmbH
- Olympus Corporation
- B Braun Melsungen
- CONMED Corporation
- I Tech
- Becton, Dickinson & Company
- Medtronic plc
- Cardinal Health
- Merit Medical System
Order a free sample PDF of the Biliary Stents Market Intelligence Study, published by Grand View Research.
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian